Landscape of biotechnological innovations: analysis of the patent portfolio operating in the Russian Federation for the period from 2005 to 2024
https://doi.org/10.19163/2307-9266-2026-14-1-18-30
Abstract
The aim. To conduct a comparative analysis of long-term trends and structural features of patenting in the field of biotechnology at the national and regional levels.
Materials and methods. The study is based on data from two patent offices: the Federal Service for Intellectual Property (Rospatent) and the Eurasian Patent Office (EAPO) for the period from 2005 to 2024. The methodology includes a quantitative analysis of patent applications with classification by applicant countries and industry areas of biotechnology.
Results. It was found that the share of biotechnological patents is 4.68% in Rospatent and 8.33% in EAPO. The phenomenon of strategic duality was revealed: in the Russian Federation, Russian applicants dominate (61% of patents), while in the EAPO their share is only 9%, while non-residents form extensive patent portfolios there. The dynamics of patent activity demonstrates a clear correlation with external factors: an increase in the activity of non-residents in the EAPO after 2014 and a shift in industry priorities in the Russian Federation from medical to industrial biotechnology after 2019. At the same time, domestic patent activity in Rospatent has decreased by 16.5% the last five years.
Conclusion. The results indicate a systemic imbalance: Russia pursues a predominantly internally oriented patent strategy, focusing on the domestic market, and is significantly inferior in the formation of legal positions in the Eurasian space. The predominance of foreign patents in the EAPO creates long-term risks for the competitiveness of Russian developments in the region. The data obtained can be useful in the development of state programs to improve Russia’s competitiveness in the framework of biotechnological areas in the global market.
About the Authors
T. N. ErivantsevaRussian Federation
Candidate of Sciences (Medicine), Advisor to the Organizational and Legal Department of the Eurasian Patent Office of the Eurasian Patent Organization.
2 M. Cherkassky lane, Moscow, Russia,109012.
A. V. Alekhin
Russian Federation
General Director of LLC "UK Farmaklon"; Assistant of the BMT-3 Department of the Bauman Moscow State Technical University (National Research University).
1. 12 Krasnopresnenskaya Emb., room 1542V, Moscow, Russia, 123610.
2. 10 Presnenskaya Emb., Bldg. 2, Moscow, Russia, 125039.
References
1. Kilcheuski A, Lemesh V, Sycheva E. From biotechnology to bioeconomy. The Science and Innovations. 2016;(6(160)):8–12. EDN: WDMZIJ
2. Lachinina TA, Chistyakov MS. Biotechnologies in the Formation of the Human Civilization's Postindustrial Shape. The Economic Revival of Russia. 2021;(2(68)):130–145. DOI: 10.37930/1990-9780-2021-2-68-130-145 EDN: AOSVPI
3. Karenov RS, Bekishev KB. Biotechnology: Its role and place in scientific and technical progress. Bulletin of Karaganda University. ‘Biology Medicine Geography’ Series. 2018;91(3):53–57. EDN HTPOYD
4. Sarsadskikh AV, Eiriyan NA. Prospects for the development of the global biotechnology Market: Technological innovations and regional trends. Fundamental Research. 2025(3):84–88; DOI: 10.17513/fr.43800 EDN: OPRWVY
5. Yuan JS, Pavlovich MJ, Ragauskas AJ, Han B. Biotechnology for a sustainable future: biomass and beyond. Trends Biotechnol. 2022;40(12):1395–1398. DOI: 10.1016/j.tibtech.2022.09.020
6. Coccia M. New directions of technologies pointing the way to a sustainable global society. Sustainable Futures. 2023;5;100114. DOI: 10.1016/j.sftr.2023.100114
7. Gadzhimuradov ZM. The role of private capital in financing innovative projects in Russia: Efficiency analysis and development prospects. Human. Society. Inclusion. 2023;(S1-1):151–156. EDN: FORYXD
8. Zobov AM, Egorycheva EA, Tamas B. Problems of venture financing of biotech startups in Russia. Innovation & Investment. 2022;(11):16–20. EDN: FOFSOO
9. Zhiganova LP. The modern innovation biotechnologies in USA. Moscow Economic Journal. 2019;(12):22. DOI 10.24411/2413-046X-2019-10190 EDN: TKLELP
10. Veselova ESh. The thorny paths of Russian Biotech. ECO Journal. 2023;53(2):8-33. DOI: 10.30680/eco0131-7652-2023-2-8-33 EDN: FSDFHK
11. Aleksandrova EA, Ivanova VI, Kuznetsova MYu. The clusters and the cluster initiatives of the Russian Biopharmaceutical Industry: Identification, structure, and geography. Vestnik of Saint Petersburg University. 2019;18(3):341–374. DOI: 10.21638/11701/spbu08.2019.302 EDN: ERQKLQ
12. Yang W. 2013--Biotech back in the saddle. Nat Biotechnol. 2014;32(2):126. DOI: 10.1038/nbt.2826
13. Reznakova M, Stefankova S. New Indicators of Innovation Activity in Economic Growth Models. Journal of Competitiveness. 2022;14(3):153–172. DOI: 10.7441/joc.2022.03.09
14. DeFrancesco L. Financing breaks all records in 2020. Nat Biotechnol. 2021;39(2):133–134. DOI: 10.1038/s41587-021-00817-7
15. Senior M. Biotech bubbles during the global recession. Nat Biotechnol. 2021;39(4):408–413. DOI: 10.1038/s41587-021-00876-w
16. Kostin KB, Fridman AR. Current conjuncture and Russia's position in the global biotechnology market. Russian Journal of Innovation Economics. 2025;15(1):191–212. DOI: 10.18334/vinec.15.1.122561 EDN: RLCNNE
17. Sertkaya A, Wong HH, Jessup A, Beleche T. Key cost drivers of pharmaceutical clinical trials in the United States. Clin Trials. 2016;13(2):117–126. DOI: 10.1177/1740774515625964
18. Zhiganova LP. The modern innovation biotechnologies in USA. Moscow Economic Journal. 2019;(12):210–228. DOI: 10.24411/2413-046Х-2019-10190 EDN: TKLELP
19. Zhukov MA. Issues with Implementation Regarding the National Project “BIOECONOMICS” in the Arctic Zone of the Russian Federation. Prirodnye resursy Arktiki i Subarktiki. 2025;30(2):282–289. DOI: 10.31242/2618-9712-2025-30-2-282-289
20. Zhuravleva EV, Vorob’eva TN, Zakharova DA, Zhabinskaya VP. Achievement of the World-Class By Scientific and Educational Centres: Trends, Mechanisms, Results. Achievements of Science and Technology of AICis. 2020;34( 9):112–118. DOI: 10.24411/0235-2451-2020-10919 EDN: KDHLPQ
21. Romanova S. Technology platform as an instrument of public innovation policy. Remedium. 2011;(6):8–12. EDN: NVUTER
22. Larkin DR, Gomanova SO. Bioeconomy: International Experience and Development Trends in Russia. Education and Science for Sustainable development: Proceedings of the XVII International Scientific and Practical Conference dedicated to the 25th anniversary of the Institute of Chemistry and Problems of Sustainable Development of the D.I. Mendeleev Russian University of Chemical Technology. In 2 parts, Moscow, April 15-18, 2025. Moscow: Mendeleev Russian University of Chemical Technology. 2025:140–142. EDN: JOXYPC
23. Ivanova IK. Development of Bioeconomy in the Russian Federation. Innovative economy: prospects for development and improvement. 2025;(2(84)):34–40. EDN JPTTSE. Russian
24. Mejia C, Kajikawa Y. Patent research in academic literature. Landscape and trends with a focus on patent analytics. Front Res Metr Anal. 2025;9:1484685. DOI: 10.3389/frma.2024.1484685
25. Titova E.S, Shubenkova EV. Bioeconomics: New Technologies, Labor Productivity and Personnel Training. Russian Journal of Labour Economics. 2025;12(5):653–668. DOI: 10.18334/et.12.5.123091 EDN: OITFHP
26. Avdzeyko V.I, Karnyshev V.I, Mescheryakov R.V. Patent analysis. Identification of promising and breakthrough technologies. Russian Journal of Innovation Economics. 2018;8(1):79–90. DOI: 10.18334/vinec.8.1.38890 EDN: YWEKEI
27. Klypin AV, Vyunov SS. Patent analysis and public policy in the field of intellectual property. Science Governance and Scientometrics. 2020;15( 2):136–171. DOI: 10.33873/2686-6706.2020.15-2.136-171 EDN: PKJNUU
28. Grassano N, Napolitano L, M`barek R, Rodriguez Cerezo E, Lasarte Lopez J. Exploring the global landscape of biotech Innovation: preliminary insights from patent analysis; Publications Office of the European Union, Luxembourg; 2024. DOI: 10.2760/567451
29. Erivantseva T, Blokhina Yu, Nikitina I, Polyakova A, Ilyuin A. Why Do Patenting Search (By The Example Of Healthcare Sector). Intellectual property. Industrial property. 2021;(10):35–42. EDN: FIGJSE. Russian
30. Alisova N, Voitsekhovskaya Z, Tsikunova L. Multi-Aspect Classification of Technical Objectsusing IPC Secondary Schemes). Intellectual property. Industrial property. 2020;(1):11–20. EDN: EPKPTG. Russian
31. DaSilva EJ. The Colours of Biotechnology: Science, Development and Humankind. Electron J Biotechnol. 2004;7(3). DOI: 10.4067/S0717-34582004000300001
32. Steiner U. Biotechnology. In: Fachenglisch für BioTAs und BTAs; Springer Spektrum, Berlin, Heidelberg; 2020. DOI: 10.1007/978-3-662-60666-7_1
33. Barcelos MCS, Lupki FB, Campolina GA, Nelson DL, Molina G. The colors of biotechnology: general overview and developments of white, green and blue areas. FEMS Microbiol Lett. 2018;365(21). DOI: 10.1093/femsle/fny239
34. Ershova AK, Spiryagina KI, Klimova TS. About Biotechnology In Paints: Classification. Current issues of modern science: theory and practice of scientific research: Proceedings of the VIII All-Russian Scientific and Practical Conference. In 2 volumes, Penza, November 11-15, 2024. Penza: Penza State Technological University; 2024:115–117. EDN: ZEGMAE. Russian
35. Demina YuA. Inflow of foreign direct investment into the EAEU: Problems and prospects. Economic Development Research Journal. 2024;(10):49–56. EDN: PVHWDH
36. Davydenko EV. Direct Mutual Investments in the Eurasian Economic Union: Problems and prospects. Journal of International Economic Affairs. 2024;14( 4):749–762. DOI: 10.18334/eo.14.4.122366 EDN: AQAXLX
37. Poege F, Harhoff D, Gaessler F, Baruffaldi S. Science quality and the value of inventions. Sci Adv. 2019;5(12):eaay7323. DOI: 10.1126/sciadv.aay7323
38. Ahmadpoor M, Jones BF. The dual frontier: Patented inventions and prior scientific advance. Science. 2017;357(6351):583–587. DOI: 10.1126/science.aam9527
39. Smirnov YuG, Gorbachev SYu. Protection of intellectual activity results as a basis of innovative development. Patents and licenses. Intellectual property rights. 2012;(11):30–39. EDN: PGRRNL
40. Cherkasova TP, Ayrapetyan DA. Methodological approaches to assessing biotechnological sovereignty: an analysis of international experience and the possibility of its adaptation. Journal of International Economic Affairs. 2025;15(4):983–1002. DOI: 10.18334/eo.15.4.123988
41. Glazunova VV. Measuring Technological Development and Sovereignty. Economics of Science. – 2024;10(3):22–33. DOI: 10.22394/2410-132X-2024-10-3-22-33
42. Mokhov AA. The three BIO concept (biotechnology, biosecurity, bioeconomics) and its legal support. Lawyer. 2020;(4):9–15. DOI 10.18572/1812-3929-2020-4-9-15 EDN: QICNCN
Review
For citations:
Erivantseva T.N., Alekhin A.V. Landscape of biotechnological innovations: analysis of the patent portfolio operating in the Russian Federation for the period from 2005 to 2024. Pharmacy & Pharmacology. 2026;14(1):18-30. https://doi.org/10.19163/2307-9266-2026-14-1-18-30
JATS XML



















































